Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease
The SARS-CoV-2 coronavirus has led to a pandemic with millions of people affected. The present study finds that risk-factors for severe COVID-19 disease courses, i.e. male sex, older age and sedentary life style are associated with higher prostaglandin E2 (PGE2) serum levels in blood samples from un...
Main Authors: | Melanie Ricke-Hoch, Elisabeth Stelling, Lisa Lasswitz, Antonia P. Gunesch, Martina Kasten, Francisco J. Zapatero-Belinchón, Graham Brogden, Gisa Gerold, Thomas Pietschmann, Virginie Montiel, Jean-Luc Balligand, Federica Facciotti, Emilio Hirsch, Thomas Gausepohl, Husni Elbahesh, Guus F. Rimmelzwaan, Anne Höfer, Mark P. Kühnel, Danny Jonigk, Julian Eigendorf, Uwe Tegtbur, Lena Mink, Michaela Scherr, Thomas Illig, Axel Schambach, Tobias J. Pfeffer, Andres Hilfiker, Axel Haverich, Denise Hilfiker-Kleiner |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336874/?tool=EBI |
Similar Items
-
Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease.
by: Melanie Ricke-Hoch, et al.
Published: (2021-01-01) -
Outgrowing endothelial and smooth muscle cells for tissue engineering approaches
by: Moritz Kolster, et al.
Published: (2017-03-01) -
Characterization of Tissue Engineered Endothelial Cell Networks in Composite Collagen-Agarose Hydrogels
by: Houda Ichanti, et al.
Published: (2020-09-01) -
FDA-Approved Inhibitors of RTK/Raf Signaling Potently Impair Multiple Steps of In Vitro and Ex Vivo Influenza A Virus Infections
by: Robert Meineke, et al.
Published: (2022-09-01) -
FDA-approved Abl/EGFR/PDGFR kinase inhibitors show potent efficacy against pandemic and seasonal influenza A virus infections of human lung explants
by: Robert Meineke, et al.
Published: (2023-04-01)